Galera Therapeutics, Inc.
corporate_fare Company Profile
Galera Therapeutics, Inc. (OTC:GRTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for GRTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-07, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 19 rated 8 or above. Recent SEC coverage for GRTX spans DEFA14C, 8-K, DEFM14C, SCHEDULE 13D.
Recent high-impact activity:
- Galera Therapeutics Announces Extreme 1-for-200 Reverse Stock Split Effective July 12
- Galera Therapeutics Board Approves Extreme 1:200 Reverse Stock Split
- Galera Therapeutics Announces 1:200 Reverse Stock Split Effective July 12
- Galera Therapeutics Finalizes Reverse Merger with Obsidian, Existing Shareholders to Own 1.29% of Combined Company
- Major Shareholder Converts Preferred Stock to 6.65% Common Stake Amidst Merger Activity
feed GRTX - Latest Insights
GRTX
Jul 07, 2026, 8:53 AM EDT
GRTX
Jul 07, 2026, 8:52 AM EDT
GRTX
Jul 07, 2026, 8:49 AM EDT
GRTX
Jul 02, 2026, 4:38 PM EDT
GRTX
Jun 11, 2026, 5:30 PM EDT
GRTX
Jun 02, 2026, 4:31 PM EDT
GRTX
May 29, 2026, 4:58 PM EDT
GRTX
May 29, 2026, 4:56 PM EDT
GRTX
May 21, 2026, 5:21 PM EDT
GRTX
May 19, 2026, 4:01 PM EDT
GRTX
May 15, 2026, 6:30 AM EDT
GRTX
May 14, 2026, 7:15 AM EDT
GRTX
May 11, 2026, 4:02 PM EDT
GRTX
Apr 27, 2026, 4:14 PM EDT
GRTX
Apr 22, 2026, 9:23 AM EDT
GRTX
Apr 20, 2026, 4:58 PM EDT
GRTX
Apr 14, 2026, 2:08 PM EDT
GRTX
Apr 14, 2026, 9:18 AM EDT
GRTX
Apr 14, 2026, 8:56 AM EDT